Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of enteric-coated mycophenolate sodium in kidney transplant patients.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A One-year, Open Label Study to Investigate the Safety and the Effect of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion in de Novo Kidney Transplant Recipients. [Phase 4]
Open-label Phase 4 study assessing the safety and effects of enteric-coated mycophenolate sodium in combination with cyclosporine microemuls…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant [Phase 2, Phase 3]
Clinical trial update evaluating the safety and efficacy of FTY720 (fingolimod) in adult kidney transplant recipients, conducted in Phase 2 …
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de novo kidney transplan…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Reliability, Safety and Usability of the Transplantation Sensor System Combined With Myfortic® in Adult Kidney Transplant Patients [Phase 2]
A Phase 2 trial evaluating the reliability, safety and usability of the Transplantation Sensor System combined with Myfortic in adult kidney…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant [Phase 4]
A Phase 4 trial update evaluating conversion from mycophenolate mofetil to mycophenolate sodium in kidney transplantation; the study status …
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients [Phase 4]
Phase 4 trial update reporting efficacy and safety data for enteric-coated mycophenolate sodium in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Gastrointestinal and Health-related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil [Phase 4]
Phase 4 clinical trial update evaluating gastrointestinal effects and health-related quality of life in kidney transplant patients treated w…
-
FDA approval · 2017-02-02FDA Approved: NULOJIX — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for NULOJIX (belatacept) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen [Phase 3]
A Phase 3 trial in de novo kidney transplant patients comparing a calcineurin inhibitor–free or low-dose regimen to a standard CNI-based reg…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Study Investigating Rapamune For Post-Marketing Surveillance
Pfizer-sponsored post-marketing surveillance study evaluating Rapamune (sirolimus) in kidney transplant recipients has completed and posted …
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens [Phase 3]
This Phase 3 trial completed evaluating whether intravenous gamma globulin improves kidney transplant survival in highly sensitized patients…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: A Study To Test An Anti-Rejection Therapy After Kidney Transplantation [Phase 3]
Phase 3 clinical trial evaluating an anti-rejection therapy after kidney transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [Phase 2]
A Phase 2 study evaluating belatacept in kidney transplant recipients on stable cyclosporine or tacrolimus regimens, with or without cortico…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation [Phase 4]
Phase 4 trial update comparing Envarsus XR (extended-release tacrolimus) with standard twice-daily tacrolimus in kidney transplant recipient…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Associating Renal Transplantation With the ITN Signature of Tolerance
This clinical trial, sponsored by the National Institute of Allergy and Infectious Diseases, explored the association between kidney transpl…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen [Phase 4]
This is an update on a Phase 4 trial evaluating a tacrolimus-based immunosuppressive regimen in stable kidney transplant recipients converte…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients [Phase 2]
Phase 2 trial comparing AEB071 (sotrastaurin) to cyclosporine in kidney transplant recipients to evaluate efficacy, safety, and tolerability…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplantation [Phase 3]
Phase 3 trial results report the efficacy and safety of fingolimod (FTY720) in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy [Phase 4]
Phase 4 trial exploring switching stable transplant recipients from mycophenolate mofetil to enteric-coated mycophenolate sodium due to gast…
-
CLINICAL_TRIALS trial_result · 2016-11-16Clinical Trial Update: Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients [Phase 4]
Phase 4 study evaluating everolimus in combination with cyclosporine microemulsion in de novo kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation [Phase 4]
Phase 4 clinical trial update evaluating therapeutic monitoring of mycophenolate mofetil in kidney transplant recipients; the study is compl…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [Phase 3]
A Phase 3 study evaluating the combination of Zenapax (daclizumab) and CellCept (mycophenolate mofetil) to improve kidney function in kidney…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients
This is a completed observational study evaluating mycophenolate mofetil (CellCept) in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity T Cell Population
This clinical trial study evaluates the role of CD28null NKG2D-positive T cells in human alloimmune reactivity among kidney transplant recip…